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Management of ischemic heel ulceration
and gangrene: An evaluation of factors
associated with successful healing
Gerald S. Treiman, MD,a Gustavo S. C. Oderich, MD,a Amir Ashrafi, BA,a
and Peter A. Schneider, MDb Salt Lake City, Utah, and Honolulu, Hawaii
Objective: The objective of this study was to determine the effectiveness of treatment of
nonhealing heel ulcers and gangrene and to define those variables that are associated
with success.
Methods: A multi-institutional review was undertaken at four university or university-
affiliated hospitals of all patients with wounds of the heel and arterial insufficiency,
which was defined as absent pedal pulses and a decreased ankle/brachial index (ABI).
Risk factors, hemodynamic parameters, and arteriographic findings were statistically
analyzed to determine their effect on wound healing. Life-table analysis was used to
assess graft patency and wound healing.
Results: Ninety-one patients (57 men, 34 women) were treated for heel wounds that did
not heal for 1 to 12 months (62% of nonhealing wounds, 3 months or longer). The
mean preoperative ABI was 0.51, and 31% of wounds were infected. Of the patients,
55% had impaired renal function (Cr > 1.5), with 24% undergoing dialysis, 70% had dia-
betes, and 64% smoked cigarettes. Treatment was topical wound care for all patients and
operative wound débridement in 50%. Infrainguinal bypass was performed for 81
patients, 4 had inflow procedures, 3 had superficial femoral artery percutaneous trans-
luminal angioplasty, and 3 had primary below-knee amputation. Postoperatively, 85% of
patients had in-line flow to the foot with at least a single patent vessel, 66% had a pedal
pulse, and the mean ABI improved by 0.40, to 0.91. Follow-up ranged from 1 to 60
months (mean, 21 months), and 77 patients (85%) are currently alive. In 66 patients
(73%), the wounds healed—all within 6 months (mean, 3 months). For 14 (16%) the
wounds had not healed, and 11 patients (11%) underwent below-knee amputation. By
life-table analysis, limb salvage was 86% at 3 years. During follow-up, 75 infrainguinal
bypasses (91%) remained patent (3 secondarily) and 6 occluded, with primary assisted
patency of 87% at 3 years. All wounds in patients with occluded grafts failed to heal.
Variables found to be statistically significant in predicting healing included normal renal
function (95% healed vs 55% nonhealed, P < .002), a palpable pedal pulse (85% healed
vs 42%, P < .0015), a patent posterior tibial artery past the ankle (86% healed vs 57%,
P < .02), and the number of patent tibial arteries after bypass to the ankle (P < .0001).
Neither the ABI nor the presence of infection (defined as positive tissue cultures or the
presence of osteomyelitis), diabetes, or other cardiovascular risk factors influenced the
outcome.
Conclusions: Complete wound healing of ischemic heel ulcers or gangrene may require
up to 6 months, and short-term graft patency is of minimal benefit. Successful arterial
reconstruction, especially a patent posterior tibial artery after bypass, is effective in treat-
ing most heel ulcers or gangrene. Patients with impaired renal function are at increased
risk for failure of treatment, but their wounds may successfully heal and they should not
be denied revascularization procedures. (J Vasc Surg 2000;31:1110-8.)
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Ulceration or gangrene of the heel is frequently
difficult to treat and often ultimately leads to amputa-
tion of the foot. In contrast to lesions confined to the
toe or forefoot, these wounds often fail to heal,
despite a palpable pulse at the ankle, seemingly good
pedal perfusion, and aggressive wound care. This has
led some authors to recommend the consideration of,
without any attempt at limb salvage, primary amputa-
tion for selected individuals with heel necrosis.1,2
This difficulty with successful healing most likely
reflects many factors—limited soft tissue over the cal-
caneus, the frequent development of osteomyelitis,
difficulty in keeping pressure off the wound, and dif-
ferences in regional pedal perfusion. This study was
undertaken to better determine the response of such
wounds to interventional treatment and to identify
factors associated with successful healing.
PATIENTS AND METHODS
Patient evaluation. The records of all patients
with wounds of the heel and arterial insufficiency
seen at four teaching institutions—a university med-
ical center, a Veterans Administration hospital, and
two university-affiliated hospital from 1994 through
1999—were reviewed. Arterial insufficiency was
defined as absent pedal pulses and an ankle/brachial
index (ABI) below 1, or for patients with calcified
and noncompressible arteries, abnormal arterial
waveforms or pulse-volume recordings at the ankle.
Data collected included cardiovascular risk fac-
tors, patient demographic information, hemody-
namic parameters, arteriographic findings, operative
variables, and clinical course. Patency of tibial and
pedal arteries was evaluated on the basis of preoper-
ative arteriograms and intraoperative findings. All
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data were recorded into a computerized database
(FileMaker Pro 3.0; Microsoft Corp, Redmond,
Wash). Independent variables were then statistically
analyzed to determine their effect on wound heal-
ing. Clinical endpoints (outcomes) were categorized
as satisfactory wound healing, persistent nonhealing,
or below-knee amputation (BKA).
Initial evaluation of patients usually included a
clinical examination, the taking of plain radiographs
of the foot, the measurement of ABI and toe pres-
sures, and evaluation of Doppler waveforms at the
ankle. Infected or nonviable tissue was usually oper-
atively débrided, but major amputation was deferred
until review of vascular studies and assessment of the
patient’s ambulatory status and overall medical con-
dition. Patients with more extensive infection or
osteomyelitis were hospitalized to allow for intra-
venous antibiotic treatments and appropriate wound
care. Wounds were usually treated with saline dress-
ings, two to three times a day, in conjunction with
appropriate antibiotic coverage.
Patients underwent either contrast arteriography
or magnetic resonance angiography (MRA), with
the injection catheter frequently positioned below
the knee to allow for maximum opacification of dis-
tal vessels. MRA was often used for patients with ele-
vated creatinine levels who were not receiving
hemodialysis in an attempt to preserve renal func-
tion. Vasodilators and magnification were used when
necessary. Papaverine hydrochloride and nitroglycer-
ine were used to minimize vasospasm and improve
the visualization of smaller arteries.
The decision to proceed with revascularization
was made by the attending vascular surgeon.
Chronically nonambulatory patients or individuals
Fig 1. Life-table plot of assisted primary patency and secondary patency for infrainguinal grafts in
patients with heel ulceration or gangrene.
with nonsalvageable extremities were not considered
for bypass. The determination of a nonsalvageable
extremity was a clinical decision and was applied to
limbs where it was thought that, even with successful
revascularization, the patient would ultimately
require major amputation. In addition, many patients
who were chronically bedridden or debilitated, or
who had extensive gangrene or necrosis, were never
referred for possible vascular surgical intervention
and were not included in this series. The presence of
diabetes mellitus or renal insufficiency did not pre-
clude the decision to proceed with reconstruction.
Operative treatment. Patients with occlusive
lesions proximal to the malleolus and reconstitution
of a tibial or juxta malleolar artery usually underwent
bypass with an autogenous vein to a vessel providing
uninterrupted flow to the foot. For individuals with
more than one suitable target, the posterior tibial
artery was usually used preferentially because of the
ease of operative dissection and subsequent revision,
and because its branches frequently maximized per-
fusion to the ischemic heel. Completion duplex scans
were obtained either in the operating room or early
postoperatively to ensure technical adequacy.
Management was similar for most of the patients
in this study. Patients received aspirin preoperatively
and continued taking it postoperatively. The use of
protamine sulfate for heparin reversal was at the dis-
cretion of the operating surgeon. Patients with
hypercoagulable states or failed previous reconstruc-
tions were given coumadin. Dextran was not used.
Follow-up. Follow-up (FU) included clinical
examinations, ABIs or toe pressures with waveforms,
and regular duplex graft surveillance. Scans were
obtained postoperatively, at 1 month, 3 months,
every 3 months for the first 2 years, and then every
6 months thereafter. Graft revision was performed
for an elevated velocity ratio (VR) in the stenotic
segment compared with the proximal graft. A VR
greater than 2.5 was the usual indication for graft
repair. For patients with a VR above 2.5 not under-
going urgent graft revision, the duplex scan was usu-
ally repeated at monthly intervals until the lesion
either stabilized or progressive hemodynamic deteri-
oration prompted bypass revision.
Data analysis. Demographic variables, cardio-
vascular risk factors, details of the operative proce-
dure, and clinical course were statistically analyzed
by using the chi-square analysis to determine their
effect on wound healing. For patients with more
than one affected extremity, each limb was indepen-
dently evaluated. Results were analyzed and report-
ed in accordance with the reporting standards of the
Society for Vascular Surgery and the North
American Chapter of the International Society for
Cardiovascular Surgery.3 Assisted primary graft
patency and foot salvage were determined by the
life-table method. Assisted primary patency was
defined as continuous graft patency despite the need
for graft revision. Secondary patency was defined as
grafts that thrombosed and were subsequently
reopened with additional intervention. Foot salvage
was defined as maintenance of nonassisted ambula-
tion, with amputation, if required, limited to the
forefoot.
RESULTS
Patient population. From 1994 through 1999,
91 patients (57 men, 34 women) underwent inter-
ventional treatment for gangrene or nonhealing
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Table I. Life-table analysis of assisted primary patency of infrainguinal grafts
No. withdrawn patent due to
Interval No. of grafts No. of failed Interval patency Cumulative 
(mo) at risk at start grafts Duration Death rate patency (%) SE
1 81 1 0 0 0.99 100 0.00
3 80 3 5 1 0.96 99 1.23
6 71 5 12 2 0.91 95 2.57
9 52 0 3 0 1.00 87 4.39
12 49 0 5 3 1.00 87 4.53
15 41 0 1 0 1.00 87 4.95
18 40 0 2 1 1.00 87 5.01
21 37 0 1 0 1.00 87 5.21
24 36 0 5 1 1.00 87 5.28
27 30 0 3 1 1.00 87 5.79
30 26 0 0 0 1.00 87 6.21
33 26 0 7 0 1.00 87 6.21
36 19 0 6 1 1.00 87 7.27
ulceration of the heel resulting from atherosclerotic
peripheral vascular disease. The significant majority
of wounds resulted from pressure necrosis, usually
from prolonged immobilization, but some resulted
from poorly fitting shoes, local trauma, or had no
identified etiology. The patients ranged in age from
38 to 88 (mean, 67 years). Associated cardiovascular
risk factors included diabetes in 70%, hypertension
in 57%, impaired renal function (defined as creati-
nine level > 1.5 mg/dL, a history of dialysis or renal
transplantation) in 55%, current or past cigarette use
in 64%, cardiac disease in 72%, and hyperlipidemia
(defined as requiring medication) in 37%. The mean
ABI was 0.51, with a range of 0.23 to 0.92.
Thirteen patients had undergone a prior ipsilateral
vascular reconstruction.
The duration of nonhealing ranged from 1 to 12
months (mean, 6 months). Sixty-two percent of
wounds were present for at least 3 months. Twenty-
eight wounds were infected at some point during
the clinical course, as determined by positive tissue
cultures or the presence of osteomyelitis. Eight
patients had radiologic evidence of osteomyelitis.
However, not all patients had adequate tissue cul-
tures taken, and quantitative cultures were not rou-
tinely obtained. In addition, not all patients had
radiologic studies to determine the presence of
osteomyelitis. These results should therefore be
interpreted with caution, because not all patients
were managed in a similar fashion.
Treatment. Treatment was topical wound care
for all patients and operative débridement in 50%.
The affected extremity was maintained non-weight-
bearing, if possible, until complete healing was
obtained. Protective splints or boots were not used
routinely; their use was at the discretion of the
attending vascular surgeon. Seven patients under-
went tissue transfer to help obtain wound coverage.
Nine patients underwent limited toe or forefoot
amputation. Eighty-one patients had infrainguinal
bypass, 4 had inflow procedures, 3 had SFA PTA,
and 3 had primary BKA. The suprainguinal inflow
procedures included femorofemoral bypass in 1
patient and axillo-femoral bypass in 3 patients. The
inflow artery for the 81 infrainguinal bypasses was
the common femoral artery in 38, deep femoral
artery in 10, superficial femoral artery in 9, above-
knee popliteal in 2, below-knee popliteal in 20, and
a tibial vessel in 2 patients. The outflow artery was
the popliteal in 34, a tibial artery in 40, and a pedal
vessel in 7 patients. The conduit was reversed saphe-
nous vein in 62, arm vein in 10, composite vein in 7,
and prosthetic (knitted Dacron graft) in 2 patients.
Postoperatively, 18 grafts underwent one or
more revisions for a duplex-identified stenosis.
Operative revision was performed in 12 patients and
included patch angioplasty, interposition grafting, or
creation of an extension graft. Endovascular treat-
ment (percutaneous transluminal angioplasty) was
performed in the other six patients. Six of these
bypass grafts underwent two sequential repairs.
Eleven patients underwent BKA, 3 as a primary pro-
cedure for an unsalvageable foot, 3 after thrombosis
of arterial reconstruction, and 5 because of uncon-
trolled infection or pain despite a patent artery to
the foot.
Outcome. Follow-up on the 91 patients ranged
from 1 to 60 months (mean, 21 months). Seventy-
seven patients (85%) are currently alive, and 14
(15%) died, none as a result of uncontrolled foot
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Table II. Life-table analysis of secondary patency of infrainguinal grafts
No. withdrawn patent due to
Interval No. of grafts No. of failed Interval patency Cumulative 
(mo) at risk at start grafts Duration Death rate patency (%) SE
1 81 0 0 0 1.00 100 0
3 81 2 5 1 0.97 100 1.73
6 73 4 12 2 0.94 97 3.12
9 55 0 3 0 1.00 92 3.59
12 52 0 6 3 1.00 92 3.69
15 43 0 1 0 1.00 92 4.06
18 42 0 2 1 1.00 92 4.11
21 39 0 1 0 1.00 92 4.27
24 38 0 6 1 1.00 92 4.32
27 31 0 3 1 1.00 92 4.78
30 27 0 0 0 1.00 92 5.13
33 27 0 7 0 1.00 92 5.13
36 20 0 6 1 1.00 92 5.96
sepsis. Of the 81 infrainguinal grafts, 75 (91%)
remained patent, 3 after thrombectomy, and 6 (9%)
were occluded. Assisted primary patency was 87%,
and secondary patency was 91% at 3 years (Tables I
and II, Fig 1).
After treatment, 82 patients (90%) had at least
one patent artery to the ankle, and 9 (10%) had
occlusion of all three tibial vessels. The posterior tib-
ial artery was patent throughout its length in 48% of
patients and the anterior tibial in 21%. Forty-four
percent of patients had a palpable pulse at the ankle,
and the mean ABI improved by 0.40, from 0.51 to
0.91. Reasons for a nonpalpable pulse included
bypass grafts to the peroneal artery, grafts to tibial
arteries that did not cross the ankle, and patients
with calcified arteries where the pulse was difficult to
feel.
Sixty-six (73%) of the heel ulcers healed, 14
(16%) remained nonhealed, and 11 patients (11%)
eventually underwent BKA. For the wounds that
healed, the interval from interventional treatment to
healing ranged from 1 to 6 months (mean, 3.2
months). Seven percent of patients healed in 1
month, and 26%, 5%, 15%, and 5% healed in 2, 3, 4,
and 5 months, respectively. By life-table analysis,
limb salvage was 86% at 3 years, although some of
these patients had nonhealed wounds (Table III).
All 66 patients with satisfactory wound healing had
at least one patent tibial artery. No ancillary mea-
sures, such as splints or protective boots, were rou-
tinely used, and their use could not therefore be cor-
related with the likelihood of wound healing.
Data analysis. Cardiovascular risk factors,
patient demographic information, arteriographic
findings, and hemodynamic parameters were statisti-
cally analyzed to determine their effect on wound
healing (Table IV). After reconstruction procedures,
patients with normal renal function, cigarette smok-
ers, individuals without hyperlipidemia, patients
with a palpable pulse, those with a patent posterior
tibial artery, and individuals with at least one patent
tibial artery were statistically more likely to have
healing of their wound. No other variable was statis-
tically significant in determining outcome.
DISCUSSION
The development of a wound over the heel or
the plantar flexor tendons overlying the calcaneus is
a common problem in hospitalized debilitated and
bedridden patients. Unfortunately, these wounds
frequently progress and enlarge, with the subse-
quent development of cellulitis and local infection,
gangrene, or calcaneal osteomyelitis. Eight percent
of all cases of osteomyelitis involve the calcaneus,
with the majority occurring in patients with arterial
insufficiency.4
Skin breakdown over the heel results from pres-
sure necrosis, and healing is often impaired because
of systemic factors, as well as local conditions
uniquely affecting this tissue. Systemic factors often
include impaired wound healing from diabetes, mal-
nutrition, peripheral neuropathy, renal insufficiency,
and concurrent systemic infection or immunosup-
pression. In addition, these patients may have
impaired tissue perfusion from atherosclerotic
peripheral vascular disease, low cardiac output, or
venous insufficiency. Local factors include the rela-
tively thin layer of subcutaneous tissue, limited mus-
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Table III. Life-table analysis of limb salvage in 91 patients with heel ulceration or gangrene
Limbs withdrawn intact due to
Interval (mo) No. at start BKA Duration Death Interval salvage rate Cumulative salvage SE
0-1 91 1 0 0 .99 1.00 0.00
2-3 90 3 5 1 .97 .97 1.09
4-6 81 5 12 2 .93 .95 2.25
7-9 62 2 1 0 .97 .86 3.74
10-12 59 0 5 3 1.0 .86 4.17
13-15 51 0 1 1 1.0 .86 4.49
16-18 49 0 2 1 1.0 .86 4.58
19-21 46 0 1 2 1.0 .86 4.73
22-24 43 0 5 1 1.0 .86 4.89
25-27 37 0 3 1 1.0 .86 5.27
28-30 33 0 0 0 1.0 .86 5.58
31-33 33 0 7 0 1.0 .86 5.58
34-36 27 0 6 1 1.0 .86 6.17
BKA, Below-knee amputation.
cle coverage, difficulty maintaining immobilization,
and difficulty in avoiding direct pressure.5-10
Consequently, these wounds are often difficult
to heal and frequently need aggressive wound care
with repeated débridement and dressings, protec-
tion from local pressure, improved perfusion with
correction of flow limiting arterial lesions, and defin-
itive wound coverage with myocutaneous flaps, from
local or distant sites. In turn, this requires a coordi-
nated approach involving vascular surgeons, plastic
surgeons, rehabilitation specialists, physical thera-
pists, and nursing personnel. These wounds may
ultimately lead to amputation despite the presence
of a palpable pedal pulse and seemingly well-vascu-
larized wound coverage.1,2,11,12
No standard management protocol for these
wounds currently exists,5 but, using a variety of
approaches, some centers have now reported up to
90% limb-salvage rates in selected patients.5,4,11,13-19
However, there have been very few recent studies
evaluating the results of treatment for these wounds,
and most older reports have been from a single insti-
tution and have involved a small number of patients.
No recent reports have specifically examined the
influence of patient demographic factors, hemody-
namic and arteriographic findings, and cardiovascu-
lar risk factors on wound healing. The current multi-
institutional study was undertaken to better deter-
mine the ultimate prognosis for patients with
vascular insufficiency and wounds of the heel or cal-
caneus, and to help provide recommendations for
treatment and patient selection.
Multiple studies, not limited to patients with
heel wounds, have found that patients with lower
extremity wounds and renal failure frequently
require BKA despite a palpable pedal pulse or suc-
cessful revascularization.1,2,11,12,20-22 Our results
confirm that patients with renal insufficiency or
renal failure are at significantly increased risk for
limb loss, even with intact arterial circulation to the
foot. However, we found that the other demo-
graphic variables and cardiovascular risk factors—
including diabetes, continued cigarette use, cardiac
disease, and the presence of infection—did not
increase the risk of limb loss. However, it is possible
a type II statistical error may exist because of the rel-
atively small number of patients in this study.
Interestingly, the ABI, both before and after revas-
cularization, did not predict limb loss, but some of
these values may have been erroneous because of
vessel calcification and incompressibility.
Gentile et al,5 in a review from the University of
Arizona on 23 patients, noted that limb preservation
and the need for myocutaneous coverage depended
on regional pedal perfusion and that the specific
patent tibial arteries, as well as the patency and col-
lateral flow through the pedal arch, was of prognos-
tic value. They noted that the presence of a pedal
pulse did not always correlate with adequate circula-
tion to the heel. Gooden et al14 found that 25% of
all patients with a patent graft and a foot wound ulti-
mately came to AKA. Andros et al,12 reporting on
five patients with wounds not limited to the heel,
confirmed that a palpable pedal pulse could be pre-
sent despite proximal arterial occlusion and that
arteriography and revascularization may be required
in some of these patients. Our results also confirm
that patients with a patent bypass graft and a palpa-
ble pedal pulse, often with an ABI greater than 0.70
or 0.80, may not have their wounds heal and will
ultimately come to amputation. Five patients
required BKA despite a patent bypass graft, and 11
additional patients have still not had healing of their
wound, even after successful revascularization. We
found that limb salvage correlated with a palpable
pedal pulse, the number of patent arteries to the
ankle, and the patency of the posterior tibial artery.
Therefore, our experience supports the concept of
differences in regional pedal perfusion but also indi-
cates that the overall level of circulation to the foot,
while not predicted by the ABI, significantly affect-
ed limb salvage.
The presence of infection did not correlate with
limb loss, perhaps because adequate circulation
allowed for successful treatment of local infection, and
myocutaneous coverage adequately treated some
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Table IV. Statistical correlation of independent
variables with outcome (successful healing)
Variable P value
No. of patent tibial arteries < .0001
Renal failure < .0001














PT, Posterior tibial artery; OR, operating room; AT, anterior tib-
ial artery; ABI, ankle/brachial index.
cases of calcaneal osteomyelitis or deeper infection.
Cigarette smokers had a better outcome than did
nonsmokers, but this may reflect a type II statistical
error, different patterns of arterial disease, and possi-
bly fewer microvascular or intrapedal perfusion
deficits. The use of myocutaneous flaps was not asso-
ciated with limb salvage, but since this was not a ran-
domized study, the use of flaps was restricted to indi-
viduals with major wounds, extensive deep infection,
or wounds that did not heal despite seemingly ade-
quate perfusion. Other reports have found that flap
coverage, in the presence of good arterial circulation,
may result in limb salvage rates approaching
90%.5,4,11,13,14,19 Since all patients in this review
underwent interventional therapy, either with revas-
cularization or major amputation, we cannot deter-
mine the natural history of limited wounds treated
only with dressings or débridement, or of patients
with nonhealing wounds who were not referred for
interventional therapy. No patient during this time
underwent myocutaneous coverage alone without
vascular evaluation.
Our overall rate of wound healing was 73%, and
complete healing required from 1 to 6 months.
Many wounds required 4 to 5 months to heal, a time
that is similar to the experience of others.5 Although
formal wound measurements were not usually
recorded, all the wounds in our experience were
extensive and had been present for a minimum of 1
month (range, 1-12 months) without adequate clo-
sure. Three patients (3%) with extensive wounds,
contraindications to arterial reconstruction, and
inability to undergo the requisite myocutaneous
coverage, arterial bypass graft, and necessary long-
term follow up, underwent initial BKA. No patient
with bypass occlusion successfully healed, although
all six graft occlusions occurred within 6 months.
Even short-term bypass patency did not prove to be
adequate for limb salvage.
On the basis of this experience, optimal manage-
ment ideally includes prevention of pressure necrosis
with well-padded foot protection. For individuals
with wounds, removing additional pressure is neces-
sary, and topical dressings, antibiotics, and immobi-
lization are likely to be helpful. Patients without
clearly excellent circulation should undergo arterial
evaluation, with bypass grafting performed if this can
significantly increase perfusion. Ideally, the target
artery should be chosen to maximize regional perfu-
sion to the heel. Postoperatively, immobilization for
the initial 2 to 3 days, followed by ambulation with
the affected extremity kept non-weight-bearing may
be helpful. From our experience, we cannot recom-
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mend a rigid prosthesis. Tissue transfer is suggested
for wounds likely to require several months to heal,
but only in patients where patient and surgeon fac-
tors portend a reasonable likelihood of success.
Some studies have recommended consideration
of primary BKA for patients with wounds at least 4 to
6 cm in diameter, diabetes, and renal failure.2,14
While these individuals clearly, based on our experi-
ence, have a worse prognosis, the ability of 28
patients in our study with diabetes and renal failure
to heal suggests that arterial reconstruction should
be offered if the patient is willing to undergo the nec-
essary procedures and follow-up. Larger ulcers
undoubtedly have a worse prognosis and are more
likely to require major amputation, but we cannot
make a definitive statement based on our data since
we do not have accurate size measurements on some
of the wounds. Aggressive wound débridement,
myocutaneous tissue transfer, partial calcanectomy,
and prolonged immobilization may be required.5,4,13
CONCLUSION
This study represents a multi-institutional expe-
rience over a recent period, and all centers had the
ability to provide multispecialty evaluation and treat-
ment of these wounds. Our experience suggests that
regional differences in pedal perfusion may well be
clinically significant and that a palpable pedal pulse
clearly does not guarantee healing. A patent posteri-
or tibial artery (especially in conjunction with paten-
cy of the other tibial vessels) in patients with normal
renal function portends the highest likelihood for
success. However, even for these individuals, several
months are often required for adequate healing,
adjunctive procedures are likely to be necessary, and
early graft occlusion will likely result in limb loss.
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DISCUSSION
Dr Cambria (Boston, Mass). Gerry, I enjoyed the paper
and agree with most of its points. I have two questions.
Where did you draw the threshold for designating a
patient renal insufficiency? My second question is a practi-
cal one: you illustrated in your study that many of these
patients even after revascularization often take 3 to 6
months to heal. What do you do in terms of ambulation,
weightbearing, care, and so forth during that interval?
I enjoyed it very much.
Dr Treiman (Salt Lake City, Utah). Thank you very
much. Impaired renal function was defined as a creatinine of
greater than 1.5, a patient on hemodialysis, or a patient with
a renal transplant. Patients with a renal transplant or those
on hemodialysis were included, even if they did not have
elevated creatinines, because they had an extended prior
period of renal insufficiency and had likely developed the
associated vessel calcification and systemic complications.
To assist in healing, we tried to keep patients nonam-
bulatory. Since most of the patients were elderly and had
undergone a prior bypass, they often spent considerable
time in the hospital or in a rehabilitation facility during
which time they had physical therapy. Therapists and fami-
ly members were educated on the importance of maintain-
ing a nonweightbearing status. For those patients who
were younger, we normally recommended crutches to try
to maintain as little pressure as possible on the affected
extremity. Many patients required adjunctive and subse-
quent procedures: calcanectomies, wound debridement, or
myocutaneous tissue transfer. These patients were main-
tained with leg elevation and were on a nonweightbearing
status. Since this is a nonrandomized study, I cannot prove
whether a nonweightbearing status really makes any differ-
ence. I think our results, while not outstanding, seem to
support the general approach we are recommending.
Dr Jorgensen (Portland, Me). There are heel ulcers and
then there are heel ulcers. As you know, the big question
is with big deep ulcers where there is necrosis down to the
bone that require calcanectomy. Can you give us some
idea how many of those were involved and how you dealt
with those?
Dr Treiman. Unfortunately, we did not have pho-
tographs and detailed measurements of all of the ulcers.
The presence of osteomyelitis and infection was not statis-
tically significant in affecting the incidence of wound heal-
ing. This may represent a type II error. We only treated 21
ulcers that were infected. I cannot give you a definitive
statement. Those patients who had wounds that, in the
judgment of myself and the other attending vascular sur-
geons, clearly were thought to result in an unsalvageable
foot or an extremity, even considering the possibility of
calcanectomy or tissue transfer, underwent primary BKA.
The other thing I would caution in interpreting the
results of this study is there may be a number of patients
with these wounds who we never saw. Some patients were
referred, for example, directly to the orthopedic service for
a primary BKA. I cannot tell you what percentage of
patients with heel wounds were salvageable. The extent of
calcaneal necrosis that results in an unsalvageable extrem-
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ity cannot be determined from this study. However, in
motivated patients and with the opportunity for tissue
transfer, it may well be reasonable to proceed with
attempted limb salvage because in some patients you are
going to succeed and maintain nonassisted ambulation.
Dr Skillman (Boston, Mass). Dr Treiman, I enjoyed
your paper very much. I wonder if you have any data on
how many patients in your overall group were fully ambu-
latory even after the healing and which factors, if any, were
responsible for getting the patients back on their feet.
Could you identify in retrospect the factors that might
have prevented that in a patient who would otherwise be
able to walk?
Dr Treiman. With the exception of patients who under-
went BKA almost all of the patients remained ambulatory,
but you have to be careful with the answer. All of these
patients were thought to be ambulatory before treatment,
even with the presence of a heel wound. Therefore, after a
tibial bypass or operative debridement, they remained
ambulatory even if the wound did not heal. The fact that
almost all of our patients were ambulatory, even though
some of the wounds did not heal, reflects the patient pop-
ulation and our judgment in selecting them more so than
the nature of the wound. As far as our regimen, we tried
to maintain leg elevation and nonweightbearing status for
as long as possible. We used careful physical therapy, using
crutches or walkers. Ultimately, almost all of the patients
who healed their wounds were ambulatory, as well as a
number of patients who had nonhealed wounds but who
had been ambulatory prior to our evaluation.
Dr Maloney (Beverly, Mass). I like your paper very
much, and what I was really looking for is the adjunctive
treatments. Were you using different types of orthoses? I
serve a big rehab hospital, plus a lot of nursing homes, and
even though ambulation is very important, the problem
you will get a lot of time is heel cord shortening if you
keep patients in bed all the time. I am a great believer in
the Lenard splint. The Lenard splint keeps that heel off
and has a walking bottom. The major problem we have
been having lately is that the nursing homes, the rehab
places, and the insurance plans do not want to pay for the
Lenard splint because they are $200 to $300. Patients are
going to get these things called bunny boots, which are
useless and really do not help any. So either the patient
says “the heck with it” and goes out and just buys an extra
pair of shoes with a foam pad, or we try to get them to buy
the Lenard splint. I am just wondering if you use that type
of orthosis.
Dr Treiman. We have similar problems with insurance
companies. The other thing to remember is this is a multi-
institutional review, so the treatment and the rehabilita-
tion was not necessarily standardized among the hospitals.
I cannot tell you definitively what percentage of patients
got bunny boots and what percentage of patients got var-
ious other orthotics. There was a variety of adjunctive pro-
cedures. Sometimes we divided the Achilles tendon if nec-
essary. That was done at the discretion of the attending
surgeon, in conjunction with the recommendations of the
physical therapist. We emphasized that every one of these
patients was evaluated by rehabilitation physicians and
physical therapists. While in the hospital, a specific pro-
gram was developed for them, and the specific orthotic
was tailored to their needs. However, if it turned out the
patient did not want to pay or could not pay, we recom-
mended alternative treatment. I wish that I could provide
more information on this. All I can do is share with you
what our attempts were and hopefully the fact that we
obtained relatively good wound healing with this
approach.
Dr Brewster (Boston, Mass). Could you comment
briefly about some of these platelet-derived wound factors
and other rather expensive topical potions that are advo-
cated nowadays by some surgeons as essential to manage-
ment.
Dr Treiman. Unfortunately, this study did not address
that issue. We have used them for a variety of wounds, but
have not used them specifically for this indication. I really
cannot tell you their effectiveness based on the results of
this study. That is something we may need to look at in the
future.
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